Accumulating evidence indicates that GR signaling participates in the regulation of multiple biological processes in both hematological malignancies and solid tumors, including lung cancer, prostate cancer, breast cancer, pancreatic cancer, and bladder cancer [54]. The gene discussed is NR3C1; the disease is lung carcinoma.